help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuroda, M.
Right arrow Articles by Machinami, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuroda, M.
Right arrow Articles by Machinami, R.

American Journal of Pathology, Vol 147, 1221-1227, Copyright © 1995 by American Society for Investigative Pathology


REGULAR ARTICLES

Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma

M Kuroda, T Ishida, H Horiuchi, N Kida, H Uozaki, H Takeuchi, K Tsuji, T Imamura, S Mori and R Machinami
Department of Pathology, University of Tokyo, Japan.

Myxoid liposarcomas have a unique and specific t(12;16)q13;p11) chromosomal translocation. The breakpoint has recently been identified and shown to involve the TLS/FUS gene on chromosome 16 and the CHOP gene on chromosome 12. This translocation causes fusion of these genes resulting in the expression of a novel chimeric TLS/FUS-CHOP message. Using the polymerase chain reaction with primer sets derived from sequences of TLS/FUS and CHOP cDNAs, we could amplify three types of the fusion transcripts from seven of seven samples of myxoid and round cell liposarcomas. In six of the seven positive samples, two kinds of chimeric messenger RNAs were found that have been reported previously. However, the last sample had a novel chimeric message that had an extra sequence of 33 bp derived from the TLS/FUS gene. Thus, it was shown that these fusion transcripts had a varying extent of the sequence of TLS/FUS gene incorporated at the site of the fusion. However, the TLS/FUS-CHOP fusion transcripts were not detected in two pleomorphic liposarcomas or in three myxoid variants of malignant fibrous histiocytomas. Our findings indicate that in liposarcomas TLS/FUS-CHOP fusion transcripts have variations at the junction of chimeric messages, which was the case for Ewing's sarcoma. Detection of the chimeric message by reverse transcription polymerase chain reaction was also suggested to be a useful approach for the diagnosis of myxoid and round cell liposarcomas that have (12;16) translocation, and for distinguishing them from pleomorphic liposarcoma and myxoid variant of malignant fibrous histiocytomas.


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
T Ohguri, M Hisaoka, S Kawauchi, K Sasaki, T Aoki, S Kanemitsu, A Matsuyama, Y Korogi, and H Hashimoto
Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation
J. Clin. Pathol., September 1, 2006; 59(9): 978 - 983.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
U. Tateishi, T. Hasegawa, Y. Beppu, A. Kawai, M. Satake, and N. Moriyama
Prognostic Significance of MRI Findings in Patients with Myxoid-Round Cell Liposarcoma
Am. J. Roentgenol., March 1, 2004; 182(3): 725 - 731.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. T. Storlazzi, F. Mertens, A. Nascimento, M. Isaksson, J. Wejde, O. Brosjo, N. Mandahl, and I. Panagopoulos
Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma
Hum. Mol. Genet., September 15, 2003; 12(18): 2349 - 2358.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
U Tateishi, T Hasegawa, Y Beppu, A Kawai, and N Moriyama
Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma
J. Clin. Pathol., August 1, 2003; 56(8): 579 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
T. Hosaka, Y. Nakashima, K. Kusuzaki, H. Murata, T. Nakayama, T. Nakamata, T. Aoyama, T. Okamoto, K. Nishijo, N. Araki, et al.
A Novel Type of EWS-CHOP Fusion Gene in Two Cases of Myxoid Liposarcoma
J. Mol. Diagn., August 1, 2002; 4(3): 164 - 171.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. R. Antonescu, S. J. Tschernyavsky, R. Decuseara, D. H. Leung, J. M. Woodruff, M. F. Brennan, J. A. Bridge, J. R. Neff, J. R. Goldblum, and M. Ladanyi
Prognostic Impact of P53 Status, TLS-CHOP Fusion Transcript Structure, and Histological Grade in Myxoid Liposarcoma: A Molecular and Clinicopathologic Study of 82 Cases
Clin. Cancer Res., December 1, 2001; 7(12): 3977 - 3987.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
C. R. Antonescu, A. Elahi, M. Humphrey, M. Y. Lui, J. H. Healey, M. F. Brennan, J. M. Woodruff, S. C. Jhanwar, and M. Ladanyi
Specificity of TLS-CHOP Rearrangement for Classic Myxoid/Round Cell Liposarcoma: Absence in Predominantly Myxoid Well-Differentiated Liposarcomas
J. Mol. Diagn., August 1, 2000; 2(3): 132 - 138.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
C. R. Antonescu, A. Elahi, J. H. Healey, M. F. Brennan, M. Y. Lui, J. Lewis, S. C. Jhanwar, J. M. Woodruff, and M. Ladanyi
Monoclonality of Multifocal Myxoid Liposarcoma: Confirmation by Analysis of TLS-CHOP or EWS-CHOP Rearrangements
Clin. Cancer Res., July 1, 2000; 6(7): 2788 - 2793.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.